Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Applied DNA Sciences stock | $6.57

Own Applied DNA Sciences stock in just a few minutes.

Fact checked

Applied DNA Sciences, Inc is a security & protection services business based in the US. Applied DNA Sciences shares (APDN) are listed on the NASDAQ and all prices are listed in US Dollars. Applied DNA Sciences employs 59 staff and has a trailing 12-month revenue of around USD$1.9 million.

How to buy shares in Applied DNA Sciences

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Applied DNA Sciences. Find the stock by name or ticker symbol: APDN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Applied DNA Sciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$6.57, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Applied DNA Sciences, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Applied DNA Sciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Applied DNA Sciences share price

Use our graph to track the performance of APDN stocks over time.

Applied DNA Sciences shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$6.57
52-week rangeUSD$2.52 - USD$13.08
50-day moving average USD$6.6015
200-day moving average USD$7.8891
Wall St. target priceUSD$13.5
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.322

Buy Applied DNA Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Applied DNA Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Applied DNA Sciences price performance over time

Historical closes compared with the close of $6.57 from 2020-12-09

1 week (2021-01-11) -25.68%
1 month (2020-12-18) 27.33%
3 months (2020-10-16) -14.68%
6 months (2020-07-17) -38.77%
1 year (2020-01-17) 53.15%
2 years (2019-01-18) 1,366.52%
3 years (2018-01-18) 343.92%
5 years (2016-01-15) 126.55%

Applied DNA Sciences financials

Revenue TTM USD$1.9 million
Gross profit TTM USD$1.2 million
Return on assets TTM -105.12%
Return on equity TTM -536.06%
Profit margin 0%
Book value $1.112
Market capitalisation USD$30.7 million

TTM: trailing 12 months

Shorting Applied DNA Sciences shares

There are currently 662,175 Applied DNA Sciences shares held short by investors – that's known as Applied DNA Sciences's "short interest". This figure is 47.3% up from 449,626 last month.

There are a few different ways that this level of interest in shorting Applied DNA Sciences shares can be evaluated.

Applied DNA Sciences's "short interest ratio" (SIR)

Applied DNA Sciences's "short interest ratio" (SIR) is the quantity of Applied DNA Sciences shares currently shorted divided by the average quantity of Applied DNA Sciences shares traded daily (recently around 365842.54143646). Applied DNA Sciences's SIR currently stands at 1.81. In other words for every 100,000 Applied DNA Sciences shares traded daily on the market, roughly 1810 shares are currently held short.

However Applied DNA Sciences's short interest can also be evaluated against the total number of Applied DNA Sciences shares, or, against the total number of tradable Applied DNA Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Applied DNA Sciences's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Applied DNA Sciences shares in existence, roughly 120 shares are currently held short) or 0.1207% of the tradable shares (for every 100,000 tradable Applied DNA Sciences shares, roughly 121 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Applied DNA Sciences.

Find out more about how you can short Applied DNA Sciences stock.

Applied DNA Sciences share dividends

We're not expecting Applied DNA Sciences to pay a dividend over the next 12 months.

Have Applied DNA Sciences's shares ever split?

Applied DNA Sciences's shares were split on a 1:40 basis on 1 November 2019. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Applied DNA Sciences shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Applied DNA Sciences shares which in turn could have impacted Applied DNA Sciences's share price.

Applied DNA Sciences share price volatility

Over the last 12 months, Applied DNA Sciences's shares have ranged in value from as little as $2.52 up to $13.08. A popular way to gauge a stock's volatility is its "beta".

APDN.US volatility(beta: 1.44)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied DNA Sciences's is 1.4446. This would suggest that Applied DNA Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Applied DNA Sciences overview

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site